CN110251843A - 一种led灯珠光疗衣 - Google Patents
一种led灯珠光疗衣 Download PDFInfo
- Publication number
- CN110251843A CN110251843A CN201910715138.2A CN201910715138A CN110251843A CN 110251843 A CN110251843 A CN 110251843A CN 201910715138 A CN201910715138 A CN 201910715138A CN 110251843 A CN110251843 A CN 110251843A
- Authority
- CN
- China
- Prior art keywords
- led lamp
- lamp bead
- phototherapy
- light
- garment body
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000011324 bead Substances 0.000 title claims abstract description 35
- 238000001126 phototherapy Methods 0.000 title claims abstract description 26
- 238000001228 spectrum Methods 0.000 claims description 5
- 230000009471 action Effects 0.000 abstract description 4
- 238000005286 illumination Methods 0.000 abstract description 4
- 210000003491 skin Anatomy 0.000 description 11
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 10
- BPYKTIZUTYGOLE-IFADSCNNSA-N Bilirubin Chemical compound N1C(=O)C(C)=C(C=C)\C1=C\C1=C(C)C(CCC(O)=O)=C(CC2=C(C(C)=C(\C=C/3C(=C(C=C)C(=O)N\3)C)N2)CCC(O)=O)N1 BPYKTIZUTYGOLE-IFADSCNNSA-N 0.000 description 8
- 238000010521 absorption reaction Methods 0.000 description 7
- 206010001497 Agitation Diseases 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 210000005036 nerve Anatomy 0.000 description 6
- 208000012641 Pigmentation disease Diseases 0.000 description 5
- 230000019612 pigmentation Effects 0.000 description 5
- 210000001519 tissue Anatomy 0.000 description 5
- 230000017531 blood circulation Effects 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 238000002560 therapeutic procedure Methods 0.000 description 4
- 208000002193 Pain Diseases 0.000 description 3
- 244000154870 Viola adunca Species 0.000 description 3
- 235000005811 Viola adunca Nutrition 0.000 description 3
- 235000013487 Viola odorata Nutrition 0.000 description 3
- 235000002254 Viola papilionacea Nutrition 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 230000002708 enhancing effect Effects 0.000 description 3
- 210000002615 epidermis Anatomy 0.000 description 3
- 239000000446 fuel Substances 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 230000007246 mechanism Effects 0.000 description 3
- 210000003205 muscle Anatomy 0.000 description 3
- 230000005855 radiation Effects 0.000 description 3
- 230000029058 respiratory gaseous exchange Effects 0.000 description 3
- 208000007101 Muscle Cramp Diseases 0.000 description 2
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 2
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 2
- 230000000202 analgesic effect Effects 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 230000004087 circulation Effects 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 230000002124 endocrine Effects 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 230000001817 pituitary effect Effects 0.000 description 2
- 230000003014 reinforcing effect Effects 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- WIGIZIANZCJQQY-UHFFFAOYSA-N 4-ethyl-3-methyl-N-[2-[4-[[[(4-methylcyclohexyl)amino]-oxomethyl]sulfamoyl]phenyl]ethyl]-5-oxo-2H-pyrrole-1-carboxamide Chemical compound O=C1C(CC)=C(C)CN1C(=O)NCCC1=CC=C(S(=O)(=O)NC(=O)NC2CCC(C)CC2)C=C1 WIGIZIANZCJQQY-UHFFFAOYSA-N 0.000 description 1
- 208000021130 Bilirubin encephalopathy Diseases 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 1
- 206010008909 Chronic Hepatitis Diseases 0.000 description 1
- UCTLRSWJYQTBFZ-UHFFFAOYSA-N Dehydrocholesterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)CCCC(C)C)CCC33)C)C3=CC=C21 UCTLRSWJYQTBFZ-UHFFFAOYSA-N 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 206010016717 Fistula Diseases 0.000 description 1
- 208000007882 Gastritis Diseases 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- 239000000637 Melanocyte-Stimulating Hormone Substances 0.000 description 1
- 108010007013 Melanocyte-Stimulating Hormones Proteins 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 206010062575 Muscle contracture Diseases 0.000 description 1
- 206010050031 Muscle strain Diseases 0.000 description 1
- 201000002481 Myositis Diseases 0.000 description 1
- 206010029240 Neuritis Diseases 0.000 description 1
- 206010057249 Phagocytosis Diseases 0.000 description 1
- 208000034189 Sclerosis Diseases 0.000 description 1
- 206010039897 Sedation Diseases 0.000 description 1
- 206010040943 Skin Ulcer Diseases 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 238000003302 UV-light treatment Methods 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- 206010048038 Wound infection Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000001133 acceleration Effects 0.000 description 1
- 208000036981 active tuberculosis Diseases 0.000 description 1
- 208000030961 allergic reaction Diseases 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000008827 biological function Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 230000002308 calcification Effects 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 229910001424 calcium ion Inorganic materials 0.000 description 1
- 230000023852 carbohydrate metabolic process Effects 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- UCTLRSWJYQTBFZ-DDPQNLDTSA-N cholesta-5,7-dien-3beta-ol Chemical compound C1[C@@H](O)CC[C@]2(C)[C@@H](CC[C@@]3([C@@H]([C@H](C)CCCC(C)C)CC[C@H]33)C)C3=CC=C21 UCTLRSWJYQTBFZ-DDPQNLDTSA-N 0.000 description 1
- 210000000349 chromosome Anatomy 0.000 description 1
- 208000023652 chronic gastritis Diseases 0.000 description 1
- 208000037976 chronic inflammation Diseases 0.000 description 1
- 230000006020 chronic inflammation Effects 0.000 description 1
- 230000027288 circadian rhythm Effects 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 208000006111 contracture Diseases 0.000 description 1
- 239000012084 conversion product Substances 0.000 description 1
- 230000001054 cortical effect Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 238000000586 desensitisation Methods 0.000 description 1
- 230000000249 desinfective effect Effects 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 210000001339 epidermal cell Anatomy 0.000 description 1
- 230000003890 fistula Effects 0.000 description 1
- 239000003574 free electron Substances 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 230000002008 hemorrhagic effect Effects 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000008595 infiltration Effects 0.000 description 1
- 238000001764 infiltration Methods 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 230000000622 irritating effect Effects 0.000 description 1
- 208000006663 kernicterus Diseases 0.000 description 1
- 230000031700 light absorption Effects 0.000 description 1
- 210000002752 melanocyte Anatomy 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 208000004296 neuralgia Diseases 0.000 description 1
- 210000004940 nucleus Anatomy 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 208000005368 osteomalacia Diseases 0.000 description 1
- 230000000242 pagocytic effect Effects 0.000 description 1
- 206010033675 panniculitis Diseases 0.000 description 1
- 230000008855 peristalsis Effects 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 230000008782 phagocytosis Effects 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000003504 photosensitizing agent Substances 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 230000011514 reflex Effects 0.000 description 1
- 210000001525 retina Anatomy 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 208000007442 rickets Diseases 0.000 description 1
- 231100000241 scar Toxicity 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 210000002955 secretory cell Anatomy 0.000 description 1
- 230000036280 sedation Effects 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 231100000019 skin ulcer Toxicity 0.000 description 1
- 210000002460 smooth muscle Anatomy 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 210000004304 subcutaneous tissue Anatomy 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 201000008827 tuberculosis Diseases 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 235000005282 vitamin D3 Nutrition 0.000 description 1
- 239000011647 vitamin D3 Substances 0.000 description 1
- QYSXJUFSXHHAJI-YRZJJWOYSA-N vitamin D3 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-YRZJJWOYSA-N 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
- 229940021056 vitamin d3 Drugs 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/0626—Monitoring, verifying, controlling systems and methods
- A61N2005/0627—Dose monitoring systems and methods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/065—Light sources therefor
- A61N2005/0651—Diodes
- A61N2005/0652—Arrays of diodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/0658—Radiation therapy using light characterised by the wavelength of light used
- A61N2005/0659—Radiation therapy using light characterised by the wavelength of light used infrared
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/0658—Radiation therapy using light characterised by the wavelength of light used
- A61N2005/0661—Radiation therapy using light characterised by the wavelength of light used ultraviolet
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/0658—Radiation therapy using light characterised by the wavelength of light used
- A61N2005/0662—Visible light
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Pathology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Radiology & Medical Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Radiation-Therapy Devices (AREA)
Abstract
本发明涉及一种LED灯珠光疗衣，有效的解决了地解决了现代人晒太阳少、光疗设备成本高，不适合家用的问题；解决的技术方案包括衣服本体，衣服本体上密集分布有LED灯珠，衣服本体上设有电源和控制电路，电源为LED灯珠供电，控制电路控制LED灯珠的点亮和熄灭；本发明能够方便的进行光疗，适合家用，使用成本低，不限制使用者的行动，且光照容易控制，安全可靠。
Description
技术领域
本发明涉及光疗领域，具体是一种LED灯珠光疗衣。
背景技术
现代人多数时间都呆在屋里，出门又穿衣服遮体，人体皮肤接触日光太少。总所周知，过度的日光照射对人体有害，但是适当强度的日光照射对人体健康有益，关键在于控制好照射强度和时间。光疗就是应用日光、人造光源中的可见光线和不可见光线防治疾病的方法。光疗始于日光疗法，早在公元2世纪就有了日光疗法的记载。人工光源始于18世界末，至19世纪中，可见光、红外线、紫外线等相继形成，随后于临床治疗的各领域中得到广泛的应用和不断发展。
（一）可见光疗法：可见光能引起视网膜的光感，其波长为400~760nm，由红、橙、黄、绿、青、蓝、紫等七色光线组成。可见光的疗法包括红光、蓝光、蓝紫光及多光谱疗法。可见光的治疗作用主要是热作用和光化学热效应。人和动物的昼夜节律以及一系列的生理功能节律与自然界的照明节律(日夜交替)有密切的联系。红色、橙色、黄色光能使呼吸加快加深，使脉率增加;绿色、蓝色、紫色光可引起呼吸减慢变浅及脉率减慢;蓝光和紫光则降低神经的兴奋性，有镇静作用;红光提高神经的兴奋性，有刺激作用。同时可见光还有加强糖代谢、促进氧化过程、加强垂体功能、提高脑皮层功能、加强交感神经系统的兴奋性、增强机体免疫力等作用。1970年代以来，可见光用治疗新生儿核黄疸。胆红素对波长400~500nm左右的光线吸收最强，最大吸收波段为420~460nm ，属蓝紫光段。胆红素吸收蓝紫光后，经分解成为一系列的转化物，逐渐变成淡黄色的低分子水溶性化合物，迅速从尿液排出。光照时皮肤血流可增加224%，这有利于将体内深部的胆红素带到皮肤浅层组织处接受照射。经蓝光照射后患儿黄疸消退，血清胆红素下降，排出绿色和深棕色的稀粪。
（二）紫外光疗法：紫外线是光谱中位于紫光之外、波长小于紫光的不可见光线，其波长为400~180nm。光量子能量高，有明显的光化学效应。紫外线分为三段:①长波紫外线(400~320nm);②中波紫外线(320~250nm);③短波紫外线(250~180nm)。紫外光疗采用中波和长波紫外线。紫外线光疗有以下作用：
（1）一定剂量的紫外线照射后，经过一定的时间可出现不同程度的皮肤色素沉着。长波紫外线照射后黑色素沉着强，短波紫外线照射后色素沉着弱。黑色素可与紫外线照射下皮肤光化学过程产生的自由电子和其他化学自由基结合，防止它们对机体的损害。皮肤色素沉着的机理是:紫外线可作用于垂体-肾上腺皮质系统，加强黑色素细胞刺激素的分泌，从而促使黑色素细胞(表皮与真皮间的分泌细胞)内的黑色素颗粒从还原状态变成氧化状态，加强表皮细胞对黑色素颗粒的吞噬作用，使皮肤色素沉着加强。利用紫外线的色素沉着作用，可以治疗白癜风，尤其是长波紫外线与光敏剂配合。
（2） 对钙磷代谢的影响。紫外线可以使人体皮肤中的7-脱氢胆固醇转变成维生素D3，维生素D3具有促进肠道对钙、磷的吸收及骨组织钙化作用。可以治疗小儿佝偻病和成人软骨病。另外，钙离子对降低血管的通透性和神经兴奋性的作用，可以减轻过敏反应，是紫外线脱敏的机制之一。
（3） 调整和改善神经、内分泌、消化、循环、呼吸、血液、免疫等系统的功能。
（4）紫外线的杀菌作用: DNA主要存在于细胞核的染色体内，是细胞繁殖、发育、生长的核心。DNA对中、短波紫外线有强烈的吸收作用。故波长220~300nm的紫外线有杀菌作用。利用紫外线的杀菌作用，可以消毒清洁创面，治疗皮肤、粘膜、伤口、窦道、瘘管等的各种感染。
（三）红外光疗法：红外线的波长为760 nm~50µm，属不可见光。红外线的主要作用基础为热效应。根据生物学特点，红外线可分为两段，其一是长波红外线，波长1.5~15µm，又称远红外线。其二是短波红外线，波长760 nm~1.5µm，又称近红外线。红外线的光量子能量低，主要生物学作用为热效应而无光化学作用。人体皮肤和皮下组织是吸收红外线的主要区域，由于皮肤表皮各区对不同波长的红外线吸收率是不同的，长波红外线只能达到0.05~1mm深度，短波红外线可深达 1~10mm，皮肤及表皮下组织将吸收红外线能量转变成热，热可以引起血管扩张，血流加速，局部血循环改善，组织的营养代谢增强，血液淋巴循环的加速，促进了组织中异常产物的吸收和消除。红外线的温热作用降低了感觉神经的兴奋性，干扰了痛阈，故红外线疗法对各种原因引起的疼痛(如神经痛)均有一定的镇痛作用。热可使肌梭中γ传出神经纤维的兴奋性降低，牵张反射减弱，致使肌张力下降，肌肉松弛，如在胃肠平滑肌痉挛时，可使胃肠蠕动减弱，肌肉痉挛缓解，疼痛消除;又能使组织内血循环加快，渗出增加，小动脉和毛细血管周围出现白细胞移行浸润，吞噬细胞功能增强，抗体形成增多。由于免疫力增强，故对浅层组织的慢性炎症有吸收作用。
红外线治疗的适应征广泛，主要用于缓解肌痉挛，改善血运，止痛。例如腰肌劳损、腰椎间盘突出、肌腱炎、慢性胃炎、慢性肝炎、神经炎、皮肤溃疡、挛缩的瘢痕等。禁忌症为高热患者、出血倾向者、活动性肺结核及重症动脉硬化等。
目前的光疗设备多用于医院或保健美容机构中，设备体积大，成本昂贵，使用成本高，而且使用时限制使用者活动，不适合日常家用。
发明内容
针对上述情况，为克服现有技术之缺陷，本发明提供了一种LED灯珠光疗衣，有效的解决了地解决了现代人晒太阳少、光疗设备成本高，不适合家用的问题。
其解决的技术方案是，一种LED灯珠光疗衣，包括衣服本体，衣服本体上密集分布有LED灯珠，衣服本体上设有电源和控制电路，电源为LED灯珠供电，控制电路控制LED灯珠的点亮和熄灭。
本发明能够方便地进行光疗，适合家用，使用成本低，不限制使用者的行动，且光照容易控制，安全可靠。
附图说明
图1为本发明主视图。
具体实施方式
以下结合附图对本发明的具体实施方式作出进一步详细说明。
由图1给出，本发明包括衣服本体1，衣服本体1上密集分布有LED灯珠2，根据治疗的需要，选用多种波长的多种LED灯珠2，衣服本体1上设有电源3和控制电路4，电源3为LED灯珠2供电，控制电路4控制紫外LED灯珠2的点亮和熄灭。
所述的LED灯珠2的波长范围为400nm~760nm可见光。
所述的LED灯珠2的波长范围为180nm~400nm内的单频或复合频谱紫外光。
所述的LED灯珠2的波长范围为760 nm~50µm红外光。
所述的LED灯珠2波长范围为180nm~50µm内的包括红外光、可见光和紫外光的复合频谱光。
本发明在使用时，使用者将衣服本体1穿在身上，然后打开控制电路，点亮LED灯珠，LED灯珠发射光线对使用者皮肤进行照射，可调整和改善神经、内分泌、消化、循环、呼吸、血液、免疫系统以及促进维生素D合成、治疗皮肤病等多种生物功能。
注意，要根据不同病情或保健的需要合理选择不同波长的LED光源灯珠，同时控制光照时长和强度，避免使长时间的强光照损伤皮肤或使过多的黑色素沉积。
本发明能够使人通过穿衣就能实现光疗，适合家用，不限制使用者的行动，且光照容易控制，安全可靠。
Claims (5)
1.一种LED灯珠光疗衣，包括衣服本体（1），其特征在于，衣服本体（1）上密集分布有LED灯珠（2），根据治疗的需要，选用多种波长的多种LED灯珠（2），衣服本体（1）上设有电源（3）和控制电路（4），电源（3）为LED灯珠（2）供电，控制电路（4）控制紫外LED灯珠（2）的点亮和熄灭。
2.根据权利要求1所述的一种LED灯珠光疗衣，其特征在于，所述的LED灯珠（2）的波长范围为400nm~760nm可见光。
3.根据权利要求1所述的一种LED灯珠光疗衣，其特征在于，所述的LED灯珠（2）的波长范围为180nm~400nm内的单频或复合频谱紫外光。
4.根据权利要求1所述的一种LED灯珠光疗衣，其特征在于，所述的LED灯珠（2）的波长范围为760 nm~50µm红外光。
5.根据权利要求1所述的一种LED灯珠光疗衣，其特征在于，所述的LED灯珠（2）波长范围为180nm~50µm内的包括红外光、可见光和紫外光的复合频谱光。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201910715138.2A CN110251843A (zh) | 2019-08-05 | 2019-08-05 | 一种led灯珠光疗衣 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201910715138.2A CN110251843A (zh) | 2019-08-05 | 2019-08-05 | 一种led灯珠光疗衣 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN110251843A true CN110251843A (zh) | 2019-09-20 |
Family
ID=67912952
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201910715138.2A Pending CN110251843A (zh) | 2019-08-05 | 2019-08-05 | 一种led灯珠光疗衣 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN110251843A (zh) |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20090054953A1 (en) * | 2004-08-05 | 2009-02-26 | Photo Therapeutics Limited | Phototherapeutic Method and Apparatus |
| US20130131762A1 (en) * | 2010-08-11 | 2013-05-23 | Koninklijke Philips Electronics N.V. | Phototherapy Method and Device |
| CN106388026A (zh) * | 2016-11-30 | 2017-02-15 | 广东凯西欧照明有限公司 | 一种led光疗衣服 |
| CN211215019U (zh) * | 2019-08-05 | 2020-08-11 | 李华辉 | 一种led灯珠光疗衣 |
-
2019
- 2019-08-05 CN CN201910715138.2A patent/CN110251843A/zh active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20090054953A1 (en) * | 2004-08-05 | 2009-02-26 | Photo Therapeutics Limited | Phototherapeutic Method and Apparatus |
| US20130131762A1 (en) * | 2010-08-11 | 2013-05-23 | Koninklijke Philips Electronics N.V. | Phototherapy Method and Device |
| CN106388026A (zh) * | 2016-11-30 | 2017-02-15 | 广东凯西欧照明有限公司 | 一种led光疗衣服 |
| CN211215019U (zh) * | 2019-08-05 | 2020-08-11 | 李华辉 | 一种led灯珠光疗衣 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Yeh et al. | Light-emitting diodes—their potential in biomedical applications | |
| US5814078A (en) | Method and apparatus for regulating and improving the status of development and survival of living organisms | |
| US20140277297A1 (en) | Quantum Dot Light-Emitting Diodes for Phototherapy | |
| KR20070053408A (ko) | 피부 미백 및 치료 기능을 갖는 마스크 | |
| El Mofty et al. | PUVA and PUVB in vitiligo–are they equally effective? | |
| CN206366102U (zh) | 一种多光谱糖尿病治疗仪 | |
| CN203525150U (zh) | 光子治疗仪 | |
| CN110141750A (zh) | 一种多用途广谱治疗仪 | |
| KR20070039212A (ko) | 광화학적 무좀 치료기 | |
| CN206167649U (zh) | 光子热疗罐 | |
| CN202446683U (zh) | 一种祛痘美容led灯 | |
| CN211215019U (zh) | 一种led灯珠光疗衣 | |
| JPH0938221A (ja) | 光線治療装置 | |
| CN110251843A (zh) | 一种led灯珠光疗衣 | |
| JP2013500840A (ja) | 光力学療法を使用する癌の治療 | |
| RU157667U1 (ru) | Многофункциональный световооздоровительный прибор | |
| Rarokar et al. | Phototherapy: A critical review | |
| CN211434774U (zh) | 一种光辐射β淀粉样皮炎治疗器械、治疗毯和治疗上衣 | |
| CN112972906A (zh) | 基于红黄蓝三种波长增益的多功能led美容养身灯 | |
| CN206304234U (zh) | 便携式理疗仪 | |
| CN201120056Y (zh) | 一种低强度激光治疗装置 | |
| CN114042256B (zh) | 一种柔性光疗美容贴及面罩式光疗美容仪 | |
| RU2209098C1 (ru) | Способ лечения витилиго | |
| Ding et al. | Phototherapy for age-related brain diseases: challenges, successes and future | |
| RU2566201C1 (ru) | Способ лечения витилиго |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination |